National Institutes of Health Clinical Center (CC)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institutes of Health Clinical Center (CC) sits in the top decile of US sponsors by registered trial count (#107 of 15,742 sponsors by registered trial count).
National Institutes of Health Clinical Center (CC): 338 sponsored US clinical trials, 22 recruiting.
National Institutes of Health Clinical Center (CC) sponsors 338 registered US clinical trials on ClinicalTrials.gov, 22 of them currently recruiting, and 272 completed. 17 of these trials are in Phase 3-4 (later-stage) and 121 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 8 trials.
Top-decile sponsor footprint
National Institutes of Health Clinical Center (CC) ranks in the top decile of sponsors by registered trial count (#107 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
272 of 308 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
338 total, page 5 of 7
Influence of Genes on Sirolimus Metabolism in Patients With Kidney Transplantation
NCT00352547
Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
NCT00083057
Isoproterenol Challenge to Detect Arrhythmogenic Right Ventricular Cardiomyopathy
NCT00083395
Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma
NCT00085462
Oral Care to Reduce Mouth and Throat Infections in Critically Ill Patients
NCT00078663
Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma
NCT00077532
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate
NCT00083005
Patient-Provider Trust Among Individuals With End-Stage Kidney Disease
NCT00075036
Magnetic Resonance Imaging to Evaluate Prostate Cancer
NCT00182624
Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer
NCT00080860
Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer
NCT00078494
Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke
NCT00079469
T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies
NCT00080925
Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
NCT00430053
The Effect of Lopinavir/Ritonavir on Endothelial Function
NCT00076414
Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome
NCT00075348
Citrate Effects and Bone Density in Long-Term Apheresis Donors
NCT00073060
Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease
NCT00072826
Pharmacokinetic Interactions With Prednisolone in Healthy Volunteers and HIV-infected Patients Receiving Single-Dose Prednisone
NCT00072644
Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations
NCT00070785
Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease
NCT00069316
Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases
NCT00069342
Natural History of West Nile Virus Infection
NCT00069303
MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis
NCT00064909
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation
NCT00064311
Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin
NCT00066664
Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma
NCT00062036
Talampanel in Treating Patients With Recurrent High-Grade Glioma
NCT00064363
Study of Heart Transplant Rejection
NCT00042614
Interleukin-7 in Treating Patients With Refractory Solid Tumors
NCT00062049
Breathing Cycle Biofeedback During Computed Tomography Procedures
NCT00059137
Development of Computer-aided Detection and Diagnosis From Imaging Techniques
NCT00057252
Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia
NCT00056433
Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins
NCT00055159
Differences in Blood Levels of Nevirapine in HIV-infected Patients in Uganda and the United States
NCT00054743
Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer
NCT00057889
Study of Decision Making in Patients Participating in Phase I Clinical Trials
NCT00054223
Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers
NCT00050180
Daclizumab to Treat Chronic Immune Thrombocytopenia
NCT00049725
Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates
NCT00048256
Ethical Dilemmas in Clinical Practice: A Survey of European Physicians
NCT00352573
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy
NCT00047164
The Natural History of Upper Trapezius Myofascial Trigger Points: Comparison of Local and Remote Tissue Milieu in Normal Muscle, Latent and Active Myofascial Trigger Points Over Time
NCT00042276
Radiofrequency Ablation of Painful Soft Tissue Neoplasms
NCT00041886
Evaluating Patient Participation in Phase I Clinical Trials
NCT00043030
Magnesium Effects in Apheresis
NCT00040235
Endothelial Dysfunction as a Risk Factor in HIV Study
NCT00039663
Pilot Study: Effects of G-CSF on T Cell Function
NCT00039650
Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices
NCT00039767
Valganciclovir to Prevent Cytomegalovirus Infection in Kidney and Kidney/Pancreas Transplant Recipients
NCT00034385
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 74 |
| Phase 2 | 47 |
| Phase 3 | 6 |
| Phase 4 | 11 |
Therapeutic Areas
What is open in the National Institutes of Health Clinical Center (CC) pipeline
22 recruiting of 338 indexed (7% open); 272 completed (80%).
Phase mix: 17 late (III/IV) vs 121 early (I/II) (early-phase heavy).
Top condition: Healthy (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institutes of Health Clinical Center (CC): open-pipeline peers nationwide
Peers matched on 338 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
National Institutes of Health Clinical Center (CC) sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 338 trials (± recruiting share)
- Cedars-Sinai Medical Center · 339 trials · 21% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
- National Institute on Drug Abuse (NIDA) · 335 trials · 4% recruiting
- Children's Oncology Group · 342 trials · 10% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Alliance for Clinical Trials in Oncology · 7% recruiting · 446 trials
- NICHD Neonatal Research Network · 7% recruiting · 61 trials
- Insmed Incorporated · 6% recruiting · 31 trials
- Baylor Breast Care Center · 7% recruiting · 15 trials
Related
What to do with this National Institutes of Health Clinical Center (CC) page
338 registered trials is a research-attention snapshot, not an endorsement of National Institutes of Health Clinical Center (CC) or any single study.
- 22 of National Institutes of Health Clinical Center (CC)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition National Institutes of Health Clinical Center (CC) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. National Institutes of Health Clinical Center (CC) pipeline card: 338 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.